FIELD: chemistry.
SUBSTANCE: invention relates to 4-hydroxybenzomorphan of formula (I), wherein A is selected from -C(=O)NH2 and -C(=S)NH2; R2 and R2a are both a hydrogen atom; R3 is selected from a hydrogen atom, C3-C4cycloalkyl, alkenyl, aryl and tetrahydrofuranyl; R4 is selected from a hydrogen atom, hydroxy and a lower alkoxy group; R11 is a hydrogen atom; R12 is selected from a hydrogen atom, hydroxy and lower alkoxy group; or radicals R11 and R12 together form a carbonyl or vinyl substitute; the dotted line denotes an optional double bond. Compounds of formula (I), wherein A is selected from -C(=O)NH2 and -C(=S)NH2; R2 and R2a are both a hydrogen atom; R3 is selected from a hydrogen atom, C3-C4cycloalkyl and alkenyl; R4 is selected from a hydrogen atom and hydroxy; R11 is a hydrogen atom; R12 is selected from a hydrogen atom and hydroxy; or radicals R11 and R12 together form a carbonyl or vinyl substitute; the dotted line denotes an optional double bond, are used to prepare a medicinal agent for treating opioid receptor-mediated diseases or conditions.
EFFECT: obtaining 4-hydroxybenzomorphans, having high affinity for the opioid receptor.
11 cl, 4 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
4-HYDROXYBENZOMORPHANS | 2005 |
|
RU2415131C2 |
TRICYCLIC COMPOUNDS OF BENZOPYRAN AS ANTIARRHYTHMIC AGENTS | 2005 |
|
RU2380370C2 |
SUBSTITUTED CHROMANS | 2015 |
|
RU2718060C2 |
GENERAL SYNTHESIS OF MYRIAPORONES | 2003 |
|
RU2328492C2 |
VARIOLINE DERIVATIVES AND THEIR EMPLOYMENT AS ANTITUMOR AGENTS | 2002 |
|
RU2302419C2 |
NOVEL COUMARIN DERIVATIVES WITH ANTI-TUMOUR ACTIVITY | 2007 |
|
RU2428420C2 |
ECTEINASCEDIN DERIVATIVES, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND USES THEREOF | 2003 |
|
RU2306316C9 |
AMINE DERIVATIVES AND THEIR USE FOR TREATMENT OF OPHTHALMOLOGICAL DISEASES AND ILLNESSES | 2008 |
|
RU2536040C2 |
2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
Authors
Dates
2013-04-27—Published
2005-11-03—Filed